SCHEMBL15416402

SCHEMBL15416402

O=C(C(O)N1CCCC1)n1cnc2ccccc21

nearest known ligand 0.50

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HTT P42858 1/20 0.50
SMN1; SMN2 Q16637 3/20 0.47
LMNA P02545 1/20 0.47
STAT6 P42226 1/20 0.47
KMT2A Q03164 4/20 0.46
ASAH1 Q13510 6/20 0.44
MEN1 O00255 2/20 0.43
DNMT3A Q9Y6K1 1/20 0.42
ALDH1A1 P00352 2/20 0.41
NPC1 O15118 1/20 0.41
MAPT P10636 1/20 0.41
HPGD P15428 1/20 0.41
RAB9A P51151 1/20 0.41
HSD17B10 Q99714 1/20 0.41
GAA P10253 1/20 0.39
APAF1 O14727 1/20 0.39
EGLN3 Q9H6Z9 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15416669 0.75 POLB (0.52) HTTSMN1; SMN2LMNASTAT6KMT2A
SCHEMBL15416404 0.74 HDAC8 (0.46) HTTLMNAKMT2AMEN1DNMT3A
SCHEMBL250172 0.72 HTT (0.66) HTTSMN1; SMN2LMNASTAT6KMT2A
SCHEMBL11443588 0.72 KMT2A (0.60) HTTSMN1; SMN2LMNASTAT6KMT2A
SCHEMBL857765 0.71 SMN1; SMN2 (0.61) HTTSMN1; SMN2LMNASTAT6KMT2A
SCHEMBL24110380 0.71 SMN1; SMN2 (0.61) HTTSMN1; SMN2LMNASTAT6KMT2A
SCHEMBL24110361 0.71 SMN1; SMN2 (0.61) HTTSMN1; SMN2LMNASTAT6KMT2A
SCHEMBL24110389 0.71 SMN1; SMN2 (0.61) HTTSMN1; SMN2LMNASTAT6KMT2A
SCHEMBL5133119 0.70 KMT2A (0.57) HTTSMN1; SMN2LMNASTAT6KMT2A
SCHEMBL11882632 0.70 KMT2A (0.57) HTTSMN1; SMN2LMNASTAT6KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2872502-A1 NOVEL INDAZOLES FOR THE TREATMENT AND PROPHYLAXIS OF RESPIRATORY SYNCYTIAL VIRUS INFECTION F. Hoffmann-La Roche AG (CH) 2015-05-20 EP disclosed
WO-2014009302-A1 NOVEL INDAZOLES FOR THE TREATMENT AND PROPHYLAXIS OF RESPIRATORY SYNCYTIAL VIRUS INFECTION F. HOFFMANN-LA ROCHE AG (CH) 2014-01-16 WO disclosed